These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35890042)

  • 1. Ginger Is a Potential Therapeutic for Chronic Toxoplasmosis.
    El-Kady AM; Al-Megrin WAI; Abdel-Rahman IAM; Sayed E; Alshehri EA; Wakid MH; Baakdah FM; Mohamed K; Elshazly H; Alobaid HM; Qahl SH; Elshabrawy HA; Younis SS
    Pathogens; 2022 Jul; 11(7):. PubMed ID: 35890042
    [No Abstract]   [Full Text] [Related]  

  • 2. Zinc oxide nanoparticles produced by Zingiber officinale ameliorates acute toxoplasmosis-induced pathological and biochemical alterations and reduced parasite burden in mice model.
    El-Kady AM; S Hassan A; Mohamed K; Alfaifi MS; Elshazly H; Alamri ZZ; Wakid MH; Gattan HS; Altwaim SA; Al-Megrin WAI; Younis S
    PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011447. PubMed ID: 37410712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of spiramycin versus aminoguanidine and their combined use in experimental toxoplasmosis.
    Omar M; Abaza BE; Mousa E; Ibrahim SM; Rashed HE; Farag TI
    J Parasit Dis; 2021 Dec; 45(4):1014-1025. PubMed ID: 34789985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel insights on the therapeutic effect of levamisole on the chronic toxoplasmosis in mice model.
    Zoghroban HS; Elmansory BM; Issa YA; Eltokhy AK; Abo Safia HS; El Maghraby GM; Salama AM
    Exp Parasitol; 2023 May; 248():108515. PubMed ID: 36958594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA mmu-miR-511-5p: A promising Diagnostic Biomarker in Experimental Toxoplasmosis Using Different Strains and Infective Doses in Mice with Different Immune States Before and After Treatment.
    Mady RF; El-Temsahy MM; Issa YA; Zaghloul AS; Khedr SI
    Acta Parasitol; 2024 Jun; 69(2):1253-1266. PubMed ID: 38743178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Engineered Expression of Mitochondrial Association Factor 1b on
    English ED; Boyle JP
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30333181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen Increased Parasite Burden and Induced a Series of Histopathological and Immunohistochemical Changes During Chronic Toxoplasmosis in Experimentally Infected Mice.
    Barakat AM; El Fadaly HAM; Selem RF; Madboli AEA; Abd El-Razik KA; Hassan EA; Alghamdi AH; Elmahallawy EK
    Front Microbiol; 2022; 13():902855. PubMed ID: 35707167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic Pathological Changes in Murine Toxoplasmosis and Possible Association with Diabetes Mellitus.
    El-Kady AM; Alzahrani AM; Elshazly H; Alshehri EA; Wakid MH; Gattan HS; Al-Megrin WAI; Alfaifi MS; Mohamed K; Alharbi W; Elshabrawy HA; Younis SS
    Biomedicines; 2022 Dec; 11(1):. PubMed ID: 36672526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of Nigella sativa oil- and wheat germ oil-loaded metal organic frameworks on chronic murine toxoplasmosis.
    Mohammad OS; El Naggar HM; Abdelmaksoud HF; Barakat AM; Abdelhameed RM; Shehata MAS
    Acta Trop; 2023 Mar; 239():106823. PubMed ID: 36608751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological and ultrastructural assessment of atovaquone-proguanil hydrochloride combination in chronic murine toxoplasmosis.
    Elmehankar MS; Elhenawy AA; Aboukamar WA; Elzoheiry MA; Nabih N
    Ultrastruct Pathol; 2021 Nov; 45(6):376-383. PubMed ID: 34595988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The High Potency of Green Synthesized Copper Nanoparticles to Prevent the Toxoplasma gondii Infection in Mice.
    Albalawi AE; Alanazi AD; Alyousif MS; Sepahvand A; Ebrahimi K; Niazi M; Mahmoudvand H
    Acta Parasitol; 2021 Dec; 66(4):1472-1479. PubMed ID: 34050875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant reduction of brain cysts caused by Toxoplasma gondii after treatment with spiramycin coadministered with metronidazole in a mouse model of chronic toxoplasmosis.
    Chew WK; Segarra I; Ambu S; Mak JW
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1762-8. PubMed ID: 22271863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rudolf-Virchow Prize 1998. Award lecture. Toxoplasmosis: a model infection for studying systemic and intracerebral immune reactions].
    Deckert-Schlüter M
    Verh Dtsch Ges Pathol; 1998; 82():9-22. PubMed ID: 10095413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive prospective of triclosan and triclosan-liposomal nanoparticles against experimental infection with a cystogenic ME49 strain of Toxoplasma gondii.
    El-Zawawy LA; El-Said D; Mossallam SF; Ramadan HS; Younis SS
    Acta Trop; 2015 Jan; 141(Pt A):103-11. PubMed ID: 25305510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo effect of anti-TNF agent (etanercept) in reactivation of latent toxoplasmosis.
    El-Sayed NM; Ismail KA; Badawy AF; Elhasanein KF
    J Parasit Dis; 2016 Dec; 40(4):1459-1465. PubMed ID: 27876967
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of clofazimine against acute and chronic Toxoplasma gondii infection in mice.
    Biglari-Moghadam N; Najafzadehvarzi H; Gorgani-Firouzjaee T; Ghasemi-Kasman M
    Microb Pathog; 2023 Aug; 181():106206. PubMed ID: 37331670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of spiramycin-loaded chitosan nanoparticles treatment on acute and chronic toxoplasmosis in mice.
    Etewa SE; El-Maaty DAA; Hamza RS; Metwaly AS; Sarhan MH; Abdel-Rahman SA; Fathy GM; El-Shafey MA
    J Parasit Dis; 2018 Mar; 42(1):102-113. PubMed ID: 29491568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remarkable histopathological improvement of experimental toxoplasmosis after receiving spiramycin-chitosan nanoparticles formulation.
    Allam AF; Hagras NA; Farag HF; Osman MM; Shalaby TI; Kazem AH; Shehab AY; Mogahed NMFH
    J Parasit Dis; 2022 Mar; 46(1):166-177. PubMed ID: 35299902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of silver nanoparticles and human platelet rich-plasma versus traditional therapy in the treatment of murine chronic toxoplasmosis.
    Ibrahim SM; Al-Ghandour AMF; Mohamed SMA; Foaad HHM; El-Bahaie ES
    J Parasit Dis; 2024 Jun; 48(2):217-228. PubMed ID: 38840885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The superior efficacy of chloroquine over buparvaquone in reducing the chronic cerebral Toxoplasma gondii cysts load and improving the ultrastructural pathology in an immunocompromised murine model.
    Fahmy MEA; Abdel-Aal AA; Hassan SI; Shalaby MA; Esmat M; Abdel Shafi IR; Afife AA; Shaheen HAA
    Trop Biomed; 2023 Mar; 40(1):115-123. PubMed ID: 37356011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.